Based in Tel Aviv, the company is pioneering developer of AI-driven computational pathology cancer diagnosis system.
Ariel Gordon and Yossi Gross founded NeuroSense Therapeutics in response to family tragedies when ALS struck.
The EXJADE (deferasirox) tablets are for the treatment of chronic iron overload due to blood transfusions in patients two years of age and older.
In ranking Sheba Medical Center tenth, "Newsweek" says it is a leader in medical science and biotechnical innovation.
The Israeli pharmaceutical company is closing its tablets factory and inhalers factories on the properties this year.
The company has received a NIS 9 million grant from the Israel Innovation Authority and total investment in the new plant will be NIS 46 million.
Alango Technologies develops special earphones that compete with the leading products in the hard of hearing market and in difficult hearing conditions.
The Swiss drug development company's US chairman Michel Pettigrew tells "Globes" what Ferring is scouting for.
Dr. Yechiel Engelhard, who sold his startup to Teva, and was put in charge of digital inhalers, tells "Globes" about the value of his products.
Patent attorney Dr. Ronnie Benshafrut says Israel companies are conceding their advantages too easily.
Israeli Nobel laureate in chemistry Avram Hershko talks forthrightly about peace, democracy, academic independence, and how to do science.
The Israeli company's solution takes the new CRISPR gene-cutting technology one better.
Mazor Robotics CEO Ori Hadomi tells the 17-year story that led to the robotic surgery company's $1.64 billion exit.